|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's range||102.85 - 103.86|
|52-week range||102.85 - 103.86|
|Beta (5Y monthly)||0.77|
|PE ratio (TTM)||25.13|
|Earnings date||08 Nov 2021 - 12 Nov 2021|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
Neurocrine (NBIX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
If you buy and hold a stock for many years, you'd hope to be making a profit. Furthermore, you'd generally like to see...
It is hard to get excited after looking at Neurocrine Biosciences' (NASDAQ:NBIX) recent performance, when its stock has...